All AbMole products are for research use only, cannot be used for human consumption.
For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.
J-2156 TFA is a high potent, selective somatostatin receptor type 4 (SST4 receptor) agonist with IC50s of 0.05 nM and 0.07 nM for human and rat SST4 receptors, respectively. J-2156 TFA has anti-inflammatory activity and it is used for the relief of mechanical allodynia and mechanical hyperalgesia in the ipsilateral hindpaws in rats.
Molecular Weight | 582.59 |
Formula | C26H29F3N4O6S |
CAS Number | 2387505-73-7 |
Form | Solid |
Solubility (25°C) | Water 100 mg/mL (ultrasonic) DMSO 100 mg/mL (ultrasonic) |
Storage | Store at ≤ -20°C, protect from light, dry, sealed |
Related Somatostatin Receptor Products |
---|
L-817818
L-817818 is a potent and subtype-selective agonist of the somatostatin receptor. |
NNC 26-9100
NNC 26-9100 is a selective somatostatin sst4 receptor full agonist (Ki: 6 nM, EC50: 2 nM). |
(1R,1'S,3'R/1R,1'R,3'S)-L-054,264
(1R,1'S,3'R/1R,1'R,3'S)-L-054,264 is a selective non-peptide human somatostatin receptor subtype 2 (sst2) agonist. |
TT-232
TT-232 (CAP-232), a somatostatin derivative, is a peptide SSTR1/SSTR4 agonist. |
Cyclosomatostatin
Cyclosomatostatin is a potent somatostatin (SST) receptor antagonist. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.